Sign up for your FREE email newsletter  +

New

Storm Therapeutics raises £12m to develop cancer therapeutics

The funding will be used to identify small molecules that target RNA-modifying enzymes as the basis for the development of new cancer therapies

Europe | R and D | Therapeutic Sector | Finance

Pfizer invests $350m in global biotechnology centre in China

US drugmaker aims to advance its leading position in biosimilars manufacturing

Design and Build | Biotechnology | Finance | Asia | Manufacturing and Equipment

Brexit: alea iacta est

In a free and democratic process, the British people have expressed their wish to leave the European Union

Europe

Aspen Australia recommends SADE SP140 weight sorters

Decision to choose a weight sorter was based on reading online reviews

Measurement and Analysis | Manufacturing and Equipment

Sanofi and BI to swap Sanofi's animal health and Boehringer’s consumer healthcare businesses

Both companies expected to become global leaders in two different sectors of the pharmaceutical market

R and D | Finance

Serialisation: the winding road to implementation

The need for pharmaceutical serialisation is universally acknowledged but has led to a proliferation of national schemes with no global standardisation; Essentra Packaging looks at why serialisation is only part of the solution to counterfeiting challenges

Packaging | Regulatory

Sobi’s Elocta approved in Switzerland for the treatment of haemophilia A

Elocta is indicated for both on-demand and prophylaxis treatment of people with haemophilia A of all ages

Europe | Regulatory | Therapeutic Sector

Paperless pharma: turbocharging development and production

Alwyn Jones, Head of Pharmaceutical and Life Sciences, Siemens UK & Ireland, highlights the company’s new solution for paperless pharmaceutical production that boosts efficiency and makes it easier to introduce personalised cancer therapies, for example

Regulatory | R and D | Information Technology

Ergomed subsidiary PrimeVigilance enters US market and opens office in Boston, USA

US base gives PrimeVigilance the presence needed to support its current North American clients

North America | Regulatory | R and D

Handling highly potent materials safely

Choosing a partner to manufacture potent or highly potent materials requires more consideration than a normal CMO partnership, reports Karolina Narczykiewicz, Operations EHS Manager, Catalent

Ingredients | R and D

Further reaction to the EU referendum result

Comments from British Generic Manufacturers Association and the British Biosimilars Association, and APBI

Europe | Regulatory | R and D | Generics

Validation of disinfection protocols

Regulatory agencies require evidence that disinfection procedures used in pharma cleanrooms are effective and while disinfectants qualified by the vendor, it is also necessary to prove their performance is adequate in a real use scenario. Dr Axel Wehrmann, SGS Life Sciences, outlines the process­

Cleaning | Measurement and Analysis

In the Press

Subscriber Sign In

Why subscribe?

Most Popular

People

Most Popular Companies

Recent Features